⌘K

Home/Filings/4/0001209191-22-059720

4//SEC Filing

Bharucha David 4

Accession 0001209191-22-059720

CIK 0001408443other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:48 PM ET

Size

6.2 KB

Accession

0001209191-22-059720

Insider Transaction Report

Form 4

Period: 2022-12-01

Milestone Pharmaceuticals Inc.MIST

Chief Medical Officer

Transactions

Purchase
Common Shares
2022-12-01$4.86/sh+3,000$14,580→ 3,000 total
Purchase
Common Shares
2022-12-05$4.69/sh+7,000$32,830→ 10,000 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Milestone Pharmaceuticals Inc.

CIK 0001408443

Entity typeother

Related Parties

1

filerCIK 0001910985

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 4:48 PM ET
Size: 6.2 KB

View on SEC.gov